Alembic Pharmaceuticals Limited — Others, 27-12-2024: Trading Window

Alembic Pharmaceuticals has announced a closure of the trading window from January 1, 2025, until 48 hours following the declaration of the financial results for the quarter and nine months ending December 31, 2024. This measure aligns with the company's Code of Conduct to regulate insider trading. The date for the upcoming board meeting to consider the financial results will be communicated later. Investors may view this as a proactive step to ensure transparency, while the timing of the results could create anticipation around the company’s performance and strategy.